(+)-schisandrin B multiple interactions ISO RGD:1359591 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PELO mRNA] CTD PMID:31150632 (S)-colchicine decreases expression ISO RGD:1343336 6480464 Colchicine results in decreased expression of PELO mRNA CTD PMID:24211769 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PELO mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PELO mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1343336 6480464 Estradiol results in increased expression of PELO mRNA CTD PMID:20106945 17beta-estradiol multiple interactions ISO RGD:1343336 6480464 [Estradiol co-treated with Progesterone] results in increased expression of PELO mRNA CTD PMID:20660070 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PELO mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PELO mRNA CTD PMID:21570461 , PMID:24680724 2,4-dinitrotoluene affects expression ISO RGD:1359591 6480464 2, 4-dinitrotoluene affects the expression of PELO mRNA CTD PMID:21346803 adenine decreases expression ISO RGD:1343336 6480464 Adenine results in decreased expression of PELO mRNA CTD PMID:24211769 aflatoxin B1 increases expression ISO RGD:1343336 6480464 Aflatoxin B1 results in increased expression of PELO mRNA CTD PMID:27153756 aflatoxin B1 decreases methylation ISO RGD:1343336 6480464 Aflatoxin B1 results in decreased methylation of PELO gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:1343336 6480464 Tretinoin results in increased expression of PELO mRNA CTD PMID:17431108 more ... antirheumatic drug increases expression ISO RGD:1343336 6480464 Antirheumatic Agents results in increased expression of PELO mRNA CTD PMID:24449571 arsane multiple interactions EXP 6480464 [APOE protein affects the susceptibility to Arsenic] which results in increased expression of PELO mRNA CTD PMID:22719926 arsenic atom multiple interactions EXP 6480464 [APOE protein affects the susceptibility to Arsenic] which results in increased expression of PELO mRNA CTD PMID:22719926 benzene increases expression ISO RGD:1343336 6480464 Benzene results in increased expression of PELO mRNA CTD PMID:19162166 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of PELO mRNA CTD PMID:21569818 benzo[a]pyrene increases expression ISO RGD:1343336 6480464 Benzoapyrene results in increased expression of PELO mRNA CTD PMID:20106945 more ... benzo[e]pyrene increases methylation ISO RGD:1343336 6480464 benzoepyrene results in increased methylation of PELO exon CTD PMID:30157460 beta-naphthoflavone increases expression ISO RGD:1343336 6480464 beta-Naphthoflavone results in increased expression of PELO mRNA CTD PMID:19737606 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1343336 6480464 Mustard Gas results in decreased expression of PELO mRNA CTD PMID:12884408 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PELO mRNA CTD PMID:26063408 bisphenol A increases expression ISO RGD:1359591 6480464 bisphenol A results in increased expression of PELO mRNA CTD PMID:25181051 , PMID:30816183 cadmium atom increases expression ISO RGD:1343336 6480464 Cadmium results in increased expression of PELO mRNA CTD PMID:23369406 cadmium dichloride increases expression ISO RGD:1359591 6480464 Cadmium Chloride results in increased expression of PELO mRNA CTD PMID:19010381 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon analog results in decreased expression of PELO mRNA CTD PMID:25554681 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of PELO mRNA CTD PMID:28472532 cisplatin decreases expression ISO RGD:1343336 6480464 Cisplatin results in decreased expression of PELO mRNA CTD PMID:24211769 cobalt dichloride increases expression ISO RGD:1359591 6480464 cobaltous chloride results in increased expression of PELO mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO RGD:1343336 6480464 cobaltous chloride results in increased expression of PELO mRNA CTD PMID:19376846 , PMID:20105288 copper(II) sulfate increases expression ISO RGD:1343336 6480464 Copper Sulfate results in increased expression of PELO mRNA CTD PMID:19549813 cyclosporin A increases expression ISO RGD:1343336 6480464 Cyclosporine results in increased expression of PELO mRNA CTD PMID:20106945 more ... dibutyl phthalate increases expression ISO RGD:1359591 6480464 Dibutyl Phthalate results in increased expression of PELO mRNA CTD PMID:21266533 dorsomorphin multiple interactions ISO RGD:1343336 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1343336 6480464 Doxorubicin results in increased expression of PELO mRNA CTD PMID:29803840 entinostat increases expression ISO RGD:1343336 6480464 entinostat results in increased expression of PELO mRNA CTD PMID:27188386 entinostat multiple interactions ISO RGD:1343336 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of PELO mRNA CTD PMID:27188386 ethanol increases expression EXP 6480464 Ethanol results in increased expression of PELO mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1343336 6480464 Ethyl Methanesulfonate results in decreased expression of PELO mRNA CTD PMID:24211769 etoposide decreases expression ISO RGD:1343336 6480464 Etoposide results in decreased expression of PELO mRNA CTD PMID:24211769 flutamide increases expression ISO RGD:1359591 6480464 Flutamide results in increased expression of PELO mRNA CTD PMID:24136188 folic acid multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PELO mRNA CTD PMID:22206623 formaldehyde decreases expression ISO RGD:1343336 6480464 Formaldehyde results in decreased expression of PELO mRNA CTD PMID:20655997 hydroxyurea decreases expression ISO RGD:1343336 6480464 Hydroxyurea results in decreased expression of PELO mRNA CTD PMID:24211769 lead(0) affects expression ISO RGD:1343336 6480464 Lead affects the expression of PELO mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1343336 6480464 Lead affects the expression of PELO mRNA CTD PMID:28903495 mercury dibromide multiple interactions ISO RGD:1343336 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of PELO mRNA CTD PMID:27188386 methapyrilene increases methylation ISO RGD:1343336 6480464 Methapyrilene results in increased methylation of PELO exon CTD PMID:30157460 mitomycin C decreases expression ISO RGD:1343336 6480464 Mitomycin results in decreased expression of PELO mRNA CTD PMID:24211769 nefazodone increases expression ISO RGD:1359591 6480464 nefazodone results in increased expression of PELO mRNA CTD PMID:24136188 nickel atom decreases expression ISO RGD:1343336 6480464 Nickel results in decreased expression of PELO mRNA CTD PMID:25583101 nickel dichloride affects expression ISO RGD:1359591 6480464 nickel chloride affects the expression of PELO mRNA CTD PMID:22546817 nickel sulfate decreases expression ISO RGD:1343336 6480464 nickel sulfate results in decreased expression of PELO mRNA CTD PMID:22714537 nimesulide increases expression ISO RGD:1359591 6480464 nimesulide results in increased expression of PELO mRNA CTD PMID:24136188 oxaliplatin multiple interactions ISO RGD:1359591 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PELO mRNA CTD PMID:25729387 p-chloromercuribenzoic acid increases expression ISO RGD:1343336 6480464 p-Chloromercuribenzoic Acid results in increased expression of PELO mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1343336 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of PELO mRNA CTD PMID:27188386 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of PELO mRNA CTD PMID:17562736 pentachlorophenol increases expression EXP 6480464 Pentachlorophenol results in increased expression of PELO mRNA CTD PMID:23892564 perfluorooctanoic acid increases expression ISO RGD:1359591 6480464 perfluorooctanoic acid results in increased expression of PELO mRNA CTD PMID:19162173 phenobarbital increases expression ISO RGD:1359591 6480464 Phenobarbital results in increased expression of PELO mRNA CTD PMID:19162173 phenobarbital affects expression ISO RGD:1343336 6480464 Phenobarbital affects the expression of PELO mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:1343336 6480464 Phenylmercuric Acetate results in increased expression of PELO mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1343336 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of PELO mRNA CTD PMID:27188386 progesterone multiple interactions ISO RGD:1343336 6480464 [Estradiol co-treated with Progesterone] results in increased expression of PELO mRNA CTD PMID:20660070 quercetin decreases expression ISO RGD:1343336 6480464 Quercetin results in decreased expression of PELO mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO RGD:1343336 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 sodium dichromate increases expression ISO RGD:1359591 6480464 sodium bichromate results in increased expression of PELO mRNA CTD PMID:25993096 tetrachloromethane increases expression ISO RGD:1359591 6480464 Carbon Tetrachloride results in increased expression of PELO mRNA CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of PELO mRNA CTD PMID:31919559 tetrachloromethane multiple interactions ISO RGD:1359591 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PELO mRNA] CTD PMID:31150632 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of PELO mRNA CTD PMID:29264374 topotecan multiple interactions ISO RGD:1359591 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PELO mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:1343336 6480464 trichostatin A results in increased expression of PELO mRNA CTD PMID:24935251 urethane increases expression ISO RGD:1343336 6480464 Urethane results in increased expression of PELO mRNA CTD PMID:28818685 valdecoxib increases expression ISO RGD:1359591 6480464 valdecoxib results in increased expression of PELO mRNA CTD PMID:24136188 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of PELO mRNA CTD PMID:17292431 valproic acid multiple interactions ISO RGD:1343336 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of PELO mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1343336 6480464 Valproic Acid results in increased expression of PELO mRNA CTD PMID:24383497 more ... vincaleukoblastine affects response to substance ISO RGD:1343336 6480464 PELO protein affects the susceptibility to Vinblastine CTD PMID:16217747 vorinostat increases expression ISO RGD:1343336 6480464 vorinostat results in increased expression of PELO mRNA CTD PMID:27188386